Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk. An Open-label, Randomized, Controlled Trial Comparing Two Strategies With or Without Pharmacological Thromboprophylaxis

NCT06845423 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT06845423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06845423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk. An Open-label, Randomized, Controlled Trial Comparing Two Strategies With or Without Pharmacological Thromboprophylaxis
Lead sponsor
University Hospital, Brest
Phase
Phase 4
Overall status
Recruiting
Start date
May 16, 2025
Completion date
August 16, 2028
Enrollment
2,400 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

post partum women, venous thromboembolism (vte)